This program is not active.
Not Found
On Demand

A Blood Test for the Early Detection of Lung Cancer


Total Credits: .75 including .75 AOA Category 2-A Credit

Average Rating:
Not yet rated
State Associations:
Not Available
Faculty:
Laura Peek, PhD, PhD
Duration:
46 Minutes
Expiration:
Never expires.


Description

This lecture by Laura Peek, Ph.D. offers information and tools regarding blood testing for the early detection of lunch cancer.

Learning Objectives:

  • Describe EarlyCDT-Lung, a blood test to aid in the risk assessment, and early detection of lung cancer. 
  • Explain the benefits and limitations of EarlyCDT-Lung testing in the context of patient factors and test performance.
  • Explain how EarlyCDT-Lung complements current recommended guidelines for lung cancer screening.

Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance.  Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee.  All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

 

 

Handouts

Faculty

Laura Peek, PhD, PhD's Profile

Laura Peek, PhD, PhD Related seminars and products: 3


Laura Peek, PhD, is the Principal Scientist and Assistant Laboratory Director for Oncimmune USA which is located in De Soto, Kansas.  She attended Baker University in Kansas for her undergraduate degree in Chemistry.  She then completed a Master’s degree and a PhD in Pharmaceutical Chemistry at the University of Kansas in Lawrence, Kansas.  She worked as a post-doctoral researcher prior to joining Oncimmune.  Dr. Peek serves her profession as a Board member of the Society of Self Fellows at KU and as a Baker University Mentor. She has identified that she has an affiliation/financial interest in Oncimmune, the maker of EarlyCDT-Lung, a product she will talk about in her presentation today.  Oncimmune is sponsoring this presentation. 

 

Dr. Peek discloses that she has no relevant financial relationships with any organizaiton producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentaion.  

 


Please wait ...

Back to Top